California Department of Health Care Services
Date: March 26, 2020
Medi-Cal Fee-For-Service (FFS) Pharmacy Benefit Section 1135 Waiver Flexibilities Relative to the 2019-Novel Coronavirus (COVID-19)
Based on the March 23, 2020 approval, DHCS is issuing the following guidance relative to temporary flexibilities in dispensing policies governing off-label and investigational use of medications under the Medi-Cal FFS pharmacy benefit, which will be in effect
until further notice.
Download PDF HERE